Back to Home
Free CE/CMEAudio

Navigating Treatment Gaps in SCLC: Relapse, Resistance, and Need for New Options

Release Date

September 4, 2025

Expiration Date

September 5, 2026

Credits

0.25 CME

Specialties

General Oncology, Lung Cancer+1 more

Release Date: September 4, 2025

Expiration Date: September 4, 2026

Activity Overview

The management of extensive-stage small cell lung cancer (ES-SCLC) is poised to change substantially with recent practice-changing trial data. However, unmet needs remain, particularly with respect to optimizing disease biomarkers and novel treatment options.

This podcast features a discussion about the current standard of care in terms of unmet needs and developmental options for the management of ES-SCLC. Led by Rohit Gosain, MD; and Rahul Gosain, MD, this session features faculty experts in evaluating and treating SCLC.

Target Audience

This educational activity is for medical oncologists, nurse practitioners, physician assistants, and oncology nurses who manage patients with SCLC.

Learning Objectives

Upon successful completion of this activity, you should be better prepared to:

  • Assess efficacy data for conventional front-line and second-line treatments of ES-SCLC
  • Recognize the unmet clinical needs in SCLC and potential opportunities to improve patient outcomes
Navigating Treatment Gaps in SCLC: Relapse, Resistance, and Need for New Options

GET STARTED WITH THIS PROGRAM:

Register now to gain access to this program.

Create AccountAlready Registered? Login Here

Accreditation/Credit Designation

Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Acknowledgment of Commercial Support

This activity is supported by an educational grant from Jazz Pharmaceuticals, Inc.

Related Content

Course

Navigating Treatment Gaps in SCLC: Relapse, Resistance, and Need for New Options

Create Account